Interactions between Microbiome and DME (MICBIO)
|
Bacteria: Actinobacteria |
Bifidobacterium adolescentis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bifidobacterium adolescentis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bifidobacterium breve (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bifidobacterium breve co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bifidobacterium longum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bifidobacterium longum co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
Bifidobacterium ruminatum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Irbesartan |
Click to Show/Hide the Detail |
Drug ID |
DR0879
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bifidobacterium ruminatum co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Losartan potassium |
Click to Show/Hide the Detail |
Drug ID |
DR0984
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bifidobacterium ruminatum co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Collinsella aerofaciens (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Pitavastatin calcium |
Click to Show/Hide the Detail |
Drug ID |
DR1306
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Collinsella aerofaciens co-metabolize the drug Pitavastatin calcium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
Eggerthella lenta (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Eggerthella lenta co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Streptomyces avermitilis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Diclofenac sodium |
Click to Show/Hide the Detail |
Drug ID |
DR0488
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Streptomyces avermitilis co-metabolize the drug Diclofenac sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [7], [8] |
Bacteria: Bacteroidetes |
Bacteroides cellulosilyticus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides cellulosilyticus co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Telmisartan |
Click to Show/Hide the Detail |
Drug ID |
DR1545
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides cellulosilyticus co-metabolize the drug Telmisartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Bacteroides dorei (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
Diclofenac sodium |
Click to Show/Hide the Detail |
Drug ID |
DR0488
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) metabolizes the drug Diclofenac sodium, and Bacteroides dorei further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[6], [10] |
Irbesartan |
Click to Show/Hide the Detail |
Drug ID |
DR0879
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides dorei co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Losartan potassium |
Click to Show/Hide the Detail |
Drug ID |
DR0984
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides dorei co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides dorei co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Telmisartan |
Click to Show/Hide the Detail |
Drug ID |
DR1545
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides dorei co-metabolize the drug Telmisartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Bacteroides fragilis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
Etodolac |
Click to Show/Hide the Detail |
Drug ID |
DR0666
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides fragilis co-metabolize the drug Etodolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Ezetimibe |
Click to Show/Hide the Detail |
Drug ID |
DR0677
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides fragilis co-metabolize the drug Ezetimibe, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
Irbesartan |
Click to Show/Hide the Detail |
Drug ID |
DR0879
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides fragilis co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Losartan potassium |
Click to Show/Hide the Detail |
Drug ID |
DR0984
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides fragilis co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides fragilis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Naproxen |
Click to Show/Hide the Detail |
Drug ID |
DR1130
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides fragilis co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
Telmisartan |
Click to Show/Hide the Detail |
Drug ID |
DR1545
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides fragilis co-metabolize the drug Telmisartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Bacteroides intestinalis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides intestinalis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides ovatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Telmisartan |
Click to Show/Hide the Detail |
Drug ID |
DR1545
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides ovatus co-metabolize the drug Telmisartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Bacteroides sartorii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
Etodolac |
Click to Show/Hide the Detail |
Drug ID |
DR0666
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides sartorii co-metabolize the drug Etodolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Ezetimibe |
Click to Show/Hide the Detail |
Drug ID |
DR0677
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides sartorii co-metabolize the drug Ezetimibe, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
Irbesartan |
Click to Show/Hide the Detail |
Drug ID |
DR0879
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides sartorii co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Losartan potassium |
Click to Show/Hide the Detail |
Drug ID |
DR0984
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides sartorii co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides sartorii co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Naproxen |
Click to Show/Hide the Detail |
Drug ID |
DR1130
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides sartorii co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
Telmisartan |
Click to Show/Hide the Detail |
Drug ID |
DR1545
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides sartorii co-metabolize the drug Telmisartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Bacteroides stercoris (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Ezetimibe |
Click to Show/Hide the Detail |
Drug ID |
DR0677
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides stercoris co-metabolize the drug Ezetimibe, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
Telmisartan |
Click to Show/Hide the Detail |
Drug ID |
DR1545
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides stercoris co-metabolize the drug Telmisartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Bacteroides thetaiotaomicron (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
Etodolac |
Click to Show/Hide the Detail |
Drug ID |
DR0666
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides thetaiotaomicron co-metabolize the drug Etodolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Ezetimibe |
Click to Show/Hide the Detail |
Drug ID |
DR0677
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides thetaiotaomicron co-metabolize the drug Ezetimibe, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
Irbesartan |
Click to Show/Hide the Detail |
Drug ID |
DR0879
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides thetaiotaomicron co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides thetaiotaomicron co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
Naproxen |
Click to Show/Hide the Detail |
Drug ID |
DR1130
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides thetaiotaomicron co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
Telmisartan |
Click to Show/Hide the Detail |
Drug ID |
DR1545
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides thetaiotaomicron co-metabolize the drug Telmisartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Bacteroides uniformis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides uniformis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides vulgatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
Irbesartan |
Click to Show/Hide the Detail |
Drug ID |
DR0879
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides vulgatus co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Losartan potassium |
Click to Show/Hide the Detail |
Drug ID |
DR0984
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides vulgatus co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides vulgatus co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Naproxen |
Click to Show/Hide the Detail |
Drug ID |
DR1130
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides vulgatus co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
Telmisartan |
Click to Show/Hide the Detail |
Drug ID |
DR1545
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides vulgatus co-metabolize the drug Telmisartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Bacteroides xylanisolvens (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
Etodolac |
Click to Show/Hide the Detail |
Drug ID |
DR0666
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides xylanisolvens co-metabolize the drug Etodolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Ezetimibe |
Click to Show/Hide the Detail |
Drug ID |
DR0677
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides xylanisolvens co-metabolize the drug Ezetimibe, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
Irbesartan |
Click to Show/Hide the Detail |
Drug ID |
DR0879
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides xylanisolvens co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Losartan potassium |
Click to Show/Hide the Detail |
Drug ID |
DR0984
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides xylanisolvens co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides xylanisolvens co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Naproxen |
Click to Show/Hide the Detail |
Drug ID |
DR1130
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides xylanisolvens co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
Telmisartan |
Click to Show/Hide the Detail |
Drug ID |
DR1545
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacteroides xylanisolvens co-metabolize the drug Telmisartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Odoribacter splanchnicus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 7 Drugs Metabolized
|
Etodolac |
Click to Show/Hide the Detail |
Drug ID |
DR0666
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Odoribacter splanchnicus co-metabolize the drug Etodolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Ezetimibe |
Click to Show/Hide the Detail |
Drug ID |
DR0677
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Odoribacter splanchnicus co-metabolize the drug Ezetimibe, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
Irbesartan |
Click to Show/Hide the Detail |
Drug ID |
DR0879
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Odoribacter splanchnicus co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Losartan potassium |
Click to Show/Hide the Detail |
Drug ID |
DR0984
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Odoribacter splanchnicus co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Odoribacter splanchnicus co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Naproxen |
Click to Show/Hide the Detail |
Drug ID |
DR1130
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Odoribacter splanchnicus co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
Telmisartan |
Click to Show/Hide the Detail |
Drug ID |
DR1545
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Odoribacter splanchnicus co-metabolize the drug Telmisartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Parabacteroides distasonis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
Losartan potassium |
Click to Show/Hide the Detail |
Drug ID |
DR0984
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Parabacteroides distasonis co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Parabacteroides distasonis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Naproxen |
Click to Show/Hide the Detail |
Drug ID |
DR1130
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Parabacteroides distasonis co-metabolize the drug Naproxen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [2] |
Telmisartan |
Click to Show/Hide the Detail |
Drug ID |
DR1545
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Parabacteroides distasonis co-metabolize the drug Telmisartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [2] |
Parabacteroides johnsonii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
Irbesartan |
Click to Show/Hide the Detail |
Drug ID |
DR0879
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Parabacteroides johnsonii co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Losartan potassium |
Click to Show/Hide the Detail |
Drug ID |
DR0984
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Parabacteroides johnsonii co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Parabacteroides johnsonii co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Parabacteroides merdae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
Irbesartan |
Click to Show/Hide the Detail |
Drug ID |
DR0879
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Parabacteroides merdae co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Losartan potassium |
Click to Show/Hide the Detail |
Drug ID |
DR0984
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Parabacteroides merdae co-metabolize the drug Losartan potassium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Parabacteroides merdae co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Prevotella copri (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Prevotella copri co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteria: Firmicutes |
Bacillus megaterium (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Diclofenac sodium |
Click to Show/Hide the Detail |
Drug ID |
DR0488
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacillus megaterium co-metabolize the drug Diclofenac sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[6], [13] |
Bacillus pumilus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Gemfibrozil |
Click to Show/Hide the Detail |
Drug ID |
DR0766
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Bacillus pumilus co-metabolize the drug Gemfibrozil, which can collectively affect efficacy, safety or bioavailability of this drug. |
[14], [15] |
Blautia hansenii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
Anastrozole |
Click to Show/Hide the Detail |
Drug ID |
DR0113
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Blautia hansenii co-metabolize the drug Anastrozole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
Etodolac |
Click to Show/Hide the Detail |
Drug ID |
DR0666
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Blautia hansenii co-metabolize the drug Etodolac, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Irbesartan |
Click to Show/Hide the Detail |
Drug ID |
DR0879
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Blautia hansenii co-metabolize the drug Irbesartan, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [2] |
Clostridium botulinum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
Anastrozole |
Click to Show/Hide the Detail |
Drug ID |
DR0113
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Clostridium botulinum co-metabolize the drug Anastrozole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[16], [2] |
Ezetimibe |
Click to Show/Hide the Detail |
Drug ID |
DR0677
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Clostridium botulinum co-metabolize the drug Ezetimibe, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Clostridium botulinum co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Clostridium perfringens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Clostridium perfringens co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
Clostridium sporogenes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Ezetimibe |
Click to Show/Hide the Detail |
Drug ID |
DR0677
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Clostridium sporogenes co-metabolize the drug Ezetimibe, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [2] |
Enterocloster asparagiformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Enterocloster asparagiformis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Eubacterium limosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Eubacterium limosum co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
Faecalibacterium prausnitzii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Diclofenac sodium |
Click to Show/Hide the Detail |
Drug ID |
DR0488
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) metabolizes the drug Diclofenac sodium, and Faecalibacterium prausnitzii further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[6], [10] |
Holdemanella biformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Holdemanella biformis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Lactobacillus rhamnosus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Diclofenac sodium |
Click to Show/Hide the Detail |
Drug ID |
DR0488
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) metabolizes the drug Diclofenac sodium, and Lactobacillus rhamnosus further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[6], [10] |
Ruminococcus gnavus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Diclofenac sodium |
Click to Show/Hide the Detail |
Drug ID |
DR0488
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) metabolizes the drug Diclofenac sodium, and Ruminococcus gnavus further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[6], [10] |
Bacteria: Fusobacteria |
Fusobacterium varium (fusobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Fusobacterium varium co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
Bacteria: Lentisphaerae |
Victivallis vadensis (PVC bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Victivallis vadensis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteria: Proteobacteria |
Sphingomonas colocasiae (alpha-proteobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Ibuprofen |
Click to Show/Hide the Detail |
Drug ID |
DR0844
Drug Info
|
Interaction Mechanism |
Human UDP-glucuronosyltransferase 1A3 (UGT1A3) and Sphingomonas colocasiae co-metabolize the drug Ibuprofen, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [17] |
|
|
|
|
|
|